Evaluation of Adalimumab Biosimilar (Exemptia: ZRC 3197) in treatment of Psoriatic Arthritis with concomitant moderate to severe chronic plaque psoriasis- An open labelled prospective pilot case series
收藏Mendeley Data2024-03-27 更新2024-06-26 收录
下载链接：
https://data.mendeley.com/datasets/7bk9p3624z
下载链接
链接失效反馈官方服务：
资源简介：
Supplemental Figure 1. Change in median PASI score with time on adalimumab biosimilar (Exemptia) Supplemental Figure 2: Change in median DAPSA, IGA and PGA score (for skin and joint disease) with time on adalimumab biosimilar (Exemptia)
创建时间：
2024-01-23
